Altesa BioSciences is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Altesa BioSciences is a clinical-stage pharmaceutical company developing vapendavir, an oral antiviral medicine targeting rhinovirus to prevent acute exacerbations in chronic lung diseases such as COPD and asthma.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.